RIFAMPIN
- Product NDC
- 24658-802
- 11-digit product format
- 246580802
- Labeler code
- 24658
- Product ID
- 24658-802_1e50fbd4-91eb-4d25-a90d-1907c3a0ec02
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rifampin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
- Application
- ANDA064150
- Marketing category
- ANDA
- Marketing start
- 2023-03-14
- Substance
- RIFAMPIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Rifamycin Antibacterial [EPC], Rifamycins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- RIFAMPIN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIFAMPIN | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | VJT6J7R4TR |
| Rxcui | 198201, 198202 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 24658-802-60 | RIFAMPIN | 60 in 1 BOTTLE | CAPSULE | 60 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 24658-802 | RIFAMPIN CAPSULE [PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS] | 3 | Current NDC, 1 package rows | 20250327_28109dee-3e5e-492b-b7d9-9ba46c0b5324.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 24658-802-60 | 24658080260 | 60 CAPSULE in 1 BOTTLE (24658-802-60) | 60 capsule | 2023-03-14 | No | No | Historical |